₹1,606.90
₹-50.50 (-3.05%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹2,158 Cr
P/E
18.57
ROE
15.49%
ROCE
19.85%
About Venus Remedies Ltd
Venus Remedies is one of the handful player in pharmaceutical sector to launch injectables globally. It has world-class manufacturing facilities in Panchkula and Baddi (in India), and research and development centre under the name of Venus Medicine Research Centre.
Founded
1989
CEO
Pawan Chaudhary
Employees
1,298
HQ
Panchkula, India
About Venus Remedies Ltd
Venus Remedies is one of the handful player in pharmaceutical sector to launch injectables globally. It has world-class manufacturing facilities in Panchkula and Baddi (in India), and research and development centre under the name of Venus Medicine Research Centre.
Founded:1989
CEO:Pawan Chaudhary
Employees:1,298
HQ:Panchkula, India
Finished Products
1Sale of Products
₹1,203.01Cr2Other Operating Revenue
₹10.60Cr3Income from Research Activites
₹1.07CrRaw Materials
1Cost of material Consumed
₹692.97Cr2Purchase of Stock in Trade
₹25.04Cr3Others
₹13.07CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,044
52W Low
₹424
Volume33.80K
Avg VolumeN/A
Beta0.84
Dividend Yield0.62%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
18.57x
Valuation
P/B Ratio
3.25x
Valuation
EPS
₹86.92
Valuation
Dividend Yield
0.62%
Valuation
ROE
15.49%
Profitability
ROCE
19.85%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical FormulationRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.